# Evaluating Targeted School Interventions for Adolescent Substance Use Risk > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/ced-evaluating-targeted-school-interven-2026-10-26/ > **Published:** 2026-10-26T14:19:49-04:00 | **Last Modified / Clinically Audited:** 2026-10-26T14:19:49-04:00 > **Clinical Summary:** medical cannabis research: Physician review of The Canadian underage substance use prevention (CUSP) trial: Amended protocol for a hybrid effectiveness-imple... --- CED Clinical Relevance #88 Verified Clinical Evidence Primary literature analysis of The Canadian underage substance use prevention (CUSP) trial: Amended protocol for a hybrid effectiveness-implementation cluster randomized trial of PreVenture.. Clinical Insight | CED Clinic Identifying high-risk adolescents before substance use patterns consolidate remains a major clinical priority. The CUSP trial targets 10th-grade students using the Substance Use Risk Profile Scale, connecting high-risk personality profiles with brief psychological coping skills workshops. While implementation in real-world school environments brings severe logistical friction, including pandemic-related attrition, establishing transparent statistical analysis plans prior to unblinding preserves methodological validity. For clinicians, early risk stratification using structured tools provides a clear path toward targeted prevention, helping intercept cannabis and substance misuse before escalation into full clinical disorders. Clinical SciencePeer-ReviewedDosing ContextSafety SignalsPhysician Insight AudiencePatients, clinicians, healthcare providers, researchers, and policy analysts. Primary TopicClinical study review: Evaluating Targeted School Interventions for Adole. Source[Read the full source](https://pubmed.ncbi.nlm.nih.gov/42927776/) Table of Contents - [Evaluating Targeted School Interventions for Adolescent Substance Use Risk](#Evaluating_Targeted_School_Interventions_for_Adolescent_Substance_Use_Risk)[How to Interpret This Clinical Study](#How_to_Interpret_This_Clinical_Study)[Three Rules for Critical Reading](#Three_Rules_for_Critical_Reading) - [CED Perspective Lens: Eight Clinical Viewpoints](#CED_Perspective_Lens_Eight_Clinical_Viewpoints)[Clinical Evidence Synthesis](#Clinical_Evidence_Synthesis) - [Patient Communication](#Patient_Communication) - [Dosing & Formulations](#Dosing_Formulations) - [Safety & Side Effect Profile](#Safety_Side_Effect_Profile) - [Regulatory & Policy Dynamics](#Regulatory_Policy_Dynamics) - [Mechanisms & Physiology](#Mechanisms_Physiology) - [Research Limitations](#Research_Limitations) - [Future Outlook](#Future_Outlook) - [Frequently Asked Questions](#Frequently_Asked_Questions)[Related](#Related) # Evaluating Targeted School Interventions for Adolescent Substance Use Risk The Canadian Underage Substance Use Prevention trial evaluated PreVenture, a personality-targeted school intervention designed to curb adolescent alcohol, cannabis, and drug use, while adapting its protocol following significant pandemic-related disruptions and attrition. What This Study Teaches Us This protocol amendment documents adjustments to a three-arm cluster randomized trial (NCT04198974) evaluating the PreVenture school intervention across Grade 10 students, accommodating significant pandemic-related attrition while maintaining statistical blinding. Why This Matters Maintaining pre-specified statistical analysis plans during severe real-world trial disruptions prevents analytical bias, providing healthcare providers and policymakers with credible evidence on adolescent substance prevention. Study SnapshotPost TypePhysician-Guided Clinical Science Deep DivePrimary SourceContemporary clinical trialsPublication Date2026Oct25Evidence LevelJournal ArticleFocus AreaEvaluating Targeted School Interventions for Adolescent SubsLead AuthorsPatricia Conrod, Britt McKinnon, Hayley A Hamilton, Marvin Krank et al.DOI10.1016/j.cct.2026.108516PMIDPMID: 42927776 Clinical Bottom Line This study review translates complex data into practical clinical insights, maintaining realistic therapeutic expectations. Headline vs. Reality Truth Meter | Clinical Analysis **Mainstream Media Claim:** School-based mental health programs easily eliminate teenage cannabis and alcohol abuse. **Primary Journal Data:** Trial data collection is complete, but effectiveness results require amended protocols due to school attrition and pandemic implementation challenges. **Dr. Caplan’s Clinical Verdict:** Targeted interventions show potential, but real-world school implementation faces substantial operational hurdles that require rigorous, pre-registered statistical corrections. Primary Analysis | The Canadian underage substance use prev **Study Overview:** Adolescent substance use remains a significant public health concern, particularly among youth with elevated personality-based risk profiles. PreVenture is a brief, personality-targeted intervention shown to reduce substance-related behaviours in prior randomized trials. The Canadian Underage Substance Use Prevention (CUSP) trial was designed to evaluate the effectiveness and implementation of PreVenture under routine school conditions. CUSP is a three-arm, parallel-group, hybrid effectiveness-implementation cluster randomized controlled trial in public secondary schools across three Canadian provinces. Schools were randomized to: (1) PreVenture via a Train-the-Trainer model; (2) PreVenture Train-the-Trainer plus Implementation Facilitation; or (3) treatment-as-usual control. Grade 10 students completed baseline screening using the Substance Use Risk Profile Scale (SURPS); those scoring above predefined SURPS thresholds were invited to participate in PreVenture workshops and included in primary analyses. The primary outcome is screening positive for substance-related problems (CRAFFT score ≥ 2). Secondary outcomes include binge drinking, cannabis, illicit drug, and non-medical prescription drug use. Implementation outcomes include fidelity, reach, uptake, acceptability, and sustainability. Data collection is complete, but outcome analyses have not yet been conducted. The trial was affected by the COVID-19 pandemic and other implementation challenges, resulting in substantial attrition at both the student and school levels. This protocol documents modifications to the design and analytic plan, also reflected in the updated trial registration (NCT04198974), to ensure transparent reporting of findings. The pre-specified Statistical Analysis Plan, provided as an online supplement, was finalized and accepted by the trial steering committee prior to unblinding. NCT04198974. **Primary Source & Scope:** Published in *Contemporary clinical trials* (2026Oct25) conducted by Patricia Conrod, Britt McKinnon, Hayley A Hamilton, Marvin Krank et al.. [Primary Source Link](https://pubmed.ncbi.nlm.nih.gov/42927776/) | **Primary Record:** DOI: 10.1016/j.cct.2026.108516 | PMID: 42927776 How Strong Is This Evidence? The CUSP trial utilizes a hybrid effectiveness-implementation cluster randomized controlled design with baseline screening via validated tools like SURPS and outcome tracking via CRAFFT. Methodological rigor is preserved by locking the statistical analysis plan prior to data unblinding despite severe attrition. Where This Paper Deserves Skepticism High student and school-level attrition stemming from pandemic disruptions introduces potential selection bias that may limit internal validity. Furthermore, reliance on self-reported substance use screening tools can introduce recall or social desirability bias among high-school participants. What This Paper Does Not Show This protocol publication does not provide final efficacy data or prove whether PreVenture significantly reduced adolescent cannabis or alcohol use. It also does not establish long-term clinical superiority of implementation facilitation over standard train-the-trainer models. How This Fits With the Broader Clinical Conversation Adolescent substance use prevention has shifted over recent decades away from scare tactics and universal abstinence messaging toward targeted, skill-based cognitive behavioral strategies. Interventions that address specific underlying psychological risk factors have consistently demonstrated superior outcomes compared to broad educational lectures. Integrating these behavioral frameworks into secondary school systems requires balancing scientific fidelity with local administrative feasibility. The CUSP trial aligns with broader international efforts to establish sustainable, school-embedded mental health initiatives that identify vulnerable youth early. Editorial Commentary *Evaluating preventative healthcare in real-world educational environments frequently presents significant methodological hurdles. The CUSP trial highlights how external events like school closures can disrupt data collection across multiple regional sites. Documenting protocol adjustments prior to unblinding data reflects responsible trial stewardship.* *Targeting substance prevention based on psychological profiles rather than delivering universal lectures represents an important advancement in adolescent care. Sensation seeking and impulsivity drive different risk behaviors than anxiety sensitivity or hopelessness. Tailoring intervention strategies to these distinct mechanisms improves engagement and practical skill adoption.* *As clinical data from this trial is analyzed, attention must remain focused on both implementation fidelity and participant retention. Understanding how implementation support helps school staff deliver these programs will dictate whether school-based prevention can scale effectively into general public health practice.* What a Careful Reader Should Take Away Pre-registered protocol amendments ensure scientific integrity when evaluating school-based substance prevention, but final clinical effectiveness conclusions must await outcome data publication. [https://cedclinic.com/ask](https://cedclinic.com/ask)Ask about this study:[🧸Children and Teens](https://cedclinic.com/ask)[🛡️Safety](https://cedclinic.com/ask)[⚖️Dosing](https://cedclinic.com/ask)[🔎This study's limits](https://cedclinic.com/ask) Evidence Interpretation Guide ## How to Interpret This Clinical Study Navigating biomedical publications regarding The Canadian underage substance use preventio requires reviewing study methodology and patient eligibility. ### Three Rules for Critical Reading **Critical Rule**Verify that protocol amendments occurred prior to data unblinding. **Critical Rule**Examine how school-level attrition impacts generalizability. **Critical Rule**Assess whether personality-targeted workshops reduce CRAFFT scores in real-world settings. Key Evaluation Question Did the statistical plan adjustments adequately account for pandemic-related school attrition before unblinding? The Patient Question How can personality-focused strategies help my adolescent build resilience against early substance exposure? The Bottom Line Personality-targeted interventions represent a promising preventive framework, but protocol transparency is vital for validating their real-world impact. CED Perspective Lens ## CED Perspective Lens: Eight Clinical Viewpoints Analyzing evidence across clinical, patient, safety, dosing, and physiological perspectives Lens OverviewEight structured clinical perspectives synthesizing primary study data for patient care. #### Clinical Evidence Synthesis The CUSP trial uses a three-arm, parallel-group, hybrid effectiveness-implementation design across Canadian secondary schools. Researchers stratified Grade 10 students using the Substance Use Risk Profile Scale to identify high-risk personality traits, including sensation seeking, impulsivity, anxiety sensitivity, and hopelessness. Selected students were offered two brief 90-minute PreVenture workshops. Primary outcome evaluation focuses on positive screening for substance problems via the CRAFFT screening tool, alongside specific tracking of cannabis, alcohol, and prescription drug use rates. In everyday practice, evaluating evidence considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawayPersonality-focused screening identifies vulnerable youth early, allowing targeted interventions to address specific behavioral drivers before clinical substance disorders develop. #### Patient Communication Communicating with adolescents about cannabis and alcohol requires removing stigma and focusing on personal coping mechanisms. The PreVenture model frames substance risk through natural personality styles rather than moral judgment. Parents and healthcare providers can adopt this framework by discussing emotional regulation, stress responses, and impulsivity directly. This approach helps teenagers recognize why they might feel drawn to substance use during stressful periods. In everyday practice, evaluating patient considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawayGrounding prevention conversations in personality traits helps young patients understand their unique vulnerabilities without feeling judged or defensive. #### Dosing & Formulations Psychological interventions function through precise behavioral dosing rather than pharmacological exposure. The PreVenture model delivers two focused 90-minute group sessions tailored specifically to individual personality profiles identified by baseline screening. This concise exposure aims to teach specific cognitive-behavioral strategies during a critical developmental window. Ensuring high implementation fidelity across school facilitators determines whether this minimal exposure creates lasting clinical protection against early cannabis exposure. In everyday practice, evaluating dosing considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawayBrief cognitive interventions require precise delivery to ensure that low exposure time translates into meaningful behavioral changes. #### Safety & Side Effect Profile Early adolescent cannabis use carries documented risks for long-term cognitive development, executive function, memory retention, and mental health stability. Targeted interventions seek to mitigate these safety concerns before habitual consumption begins. Monitoring implementation safety involves ensuring that targeted workshops do not inadvertently label or isolate participating students within school peer networks. Maintaining confidentiality during school-wide screening protects student well-being throughout the study. In everyday practice, evaluating safety considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawayEarly prevention strategies safeguard adolescent brain development while requiring careful school protocol design to maintain student privacy. #### Regulatory & Policy Dynamics Policy frameworks surrounding adolescent substance prevention require strict alignment between public health departments and regional school boards. Implementing evidence-based programs across diverse provincial educational systems requires administrative flexibility and sustained institutional funding. The CUSP trial protocol modifications highlight the regulatory necessity of updating public trial registries when severe disruptions occur. Transparently documenting changes to statistical analysis plans maintains integrity in public health research. In everyday practice, evaluating regulatory considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawayFormal registry updates and pre-specified analysis plans ensure transparency when real-world challenges disrupt school-based health research protocols. #### Mechanisms & Physiology The biological mechanism underlying personality-targeted prevention relies on enhancing top-down cognitive control over emotional and behavioral impulses. Distinct personality traits like sensation seeking and anxiety sensitivity reflect neurobiological differences in brain reward processing and threat perception. By teaching targeted cognitive-behavioral techniques, the intervention strengthens prefrontal executive regulation over limbic responses. This mental scaffolding reduces impulsive decision-making during high-risk social scenarios involving cannabis or alcohol. In everyday practice, evaluating mechanisms considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawayCognitive-behavioral skill building strengthens prefrontal executive function, empowering adolescents to regulate neural reward drives during high-risk situations. #### Research Limitations The primary limitation of the CUSP trial stems from substantial school-level and student-level attrition compounded by widespread COVID-19 pandemic disruptions. Unexpected disruptions in routine classroom attendance created missing data points and potential selection bias among participating students. Protocol amendments were necessary to adjust statistical models prior to unblinding. While these adjustments preserve analytic rigor, real-world execution challenges mean implementation outcomes may differ across school districts. In everyday practice, evaluating limits considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawaySevere sample attrition and external pandemic disruptions require formal protocol adjustments, limiting the direct generalizability of school implementation findings. #### Future Outlook Future public health strategies will increasingly rely on scalable, personality-targeted interventions integrated directly within educational systems. Blending train-the-trainer models with dedicated external implementation facilitation may enhance intervention sustainability across diverse school environments. Once final outcome analyses are completed, data from the CUSP trial will clarify how school-based prevention can be effectively adapted during unexpected crisis conditions. These insights will guide future health policies for adolescent cannabis and substance use prevention. In everyday practice, evaluating outlook considerations requires assessing individual patient tolerance, baseline functional capacity, and verifiable product profiles rather than generalizing from preliminary reports alone. Lens takeawayAdapting school-based prevention programs to withstand real-world operational challenges will remain critical for long-term public health success. Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care [Dr. Benjamin Caplan, MD](https://cedclinic.com/drcaplan/) Board-Certified Family Physician • Cannabinoid Specialist • 350k+ Patients Evaluated A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Meet Dr. Caplan (CV)](https://cedclinic.com/drcaplan/) [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](http://CEDclinic.com/book) [Cannabis Care](http://CEDclinic.com/book) [https://cedclinic.com/drcaplan/](https://cedclinic.com/drcaplan/) Share this Evidence Watch [X](https://twitter.com/intent/tweet?text=Evaluating+Targeted+School+Interventions+for+Adolescent+Substance+Use+Risk&url=https%3A%2F%2Fcedclinic.com%2Fced-evaluating-targeted-school-interven-2026-10-26%2F) [LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fced-evaluating-targeted-school-interven-2026-10-26%2F) [BlueSky](https://bsky.app/intent/compose?text=Evaluating+Targeted+School+Interventions+for+Adolescent+Substance+Use+Risk%20https%3A%2F%2Fcedclinic.com%2Fced-evaluating-targeted-school-interven-2026-10-26%2F) [Instagram](https://www.instagram.com/drcaplan/) [Substack](https://doctorapprovedcannabis.substack.com/) [RSS](https://cedclinic.com/feed/) Source: [Primary Source: The Canadian underage substance use prevention (CUSP) trial: Amended protocol for a hybrid effectiveness-implementation cluster randomized trial of PreVenture.](https://pubmed.ncbi.nlm.nih.gov/42927776/) Related Reading at CED ClinicContinue exploring the evidence[Adolescent Cannabis Use and Its Impact on Cognitive Development: Insights from the ABCD Study](https://cedclinic.com/adolescent-cannabis-use-cognitive-development-risk/) More on this topic: Long-term ABCD study findings on adolescent brain development, executive function, and early cannabis susceptibility. [More on this topic: Adolescent brain health](https://cedclinic.com/adolescent-cannabis-use-cognitive-development-risk/)[PP-01 for Cannabis Withdrawal: What a 14-Person Trial Found](https://cedclinic.com/pp01-cannabis-withdrawal-proof-of-concept/) More on this topic: Clinical trial data evaluating pharmacological interventions and supportive care for cannabis withdrawal. [More on this topic: Withdrawal management](https://cedclinic.com/pp01-cannabis-withdrawal-proof-of-concept/)[Cannabis Use Disorder Is Rising Among US Adults](https://cedclinic.com/cannabis-use-disorder-rising-us-adults-2026/) More on this topic: Epidemiological evaluation of diagnostic trends, screening tools, and evidence-based patient counseling. [More on this topic: CUD trends & screening](https://cedclinic.com/cannabis-use-disorder-rising-us-adults-2026/) ## Frequently Asked Questions What is the CUSP trial evaluating? The Canadian Underage Substance Use Prevention trial evaluates the PreVenture personality-targeted intervention to reduce substance misuse among 10th-grade students in public secondary schools. How does PreVenture identify students at risk for substance use? PreVenture screens students using the Substance Use Risk Profile Scale, which measures four specific risk traits: sensation seeking, impulsivity, anxiety sensitivity, and hopelessness. What substances are monitored in this study? The trial tracks participant screening scores for general substance-related problems using the CRAFFT tool, with secondary outcomes focusing on cannabis, alcohol, illicit drugs, and non-medical prescription drugs. Why was the CUSP trial protocol amended? Unexpected implementation challenges and school disruptions caused by the COVID-19 pandemic led to substantial participant attrition, requiring adjustments to the statistical analysis plan before data unblinding. What are the three study arms in the CUSP trial? Schools were randomized to either PreVenture delivered via a Train-the-Trainer model, PreVenture Train-the-Trainer plus Implementation Facilitation, or standard treatment-as-usual controls. How long are the PreVenture workshops for students? Students scoring above high-risk personality thresholds are invited to complete two brief 90-minute skill-building workshops tailored to their specific risk profile. Why is pre-registering trial modifications important in research? Finalizing and locking the statistical analysis plan prior to unblinding prevents bias, ensuring transparent reporting when evaluating study outcomes. Does PreVenture replace traditional school drug education programs? PreVenture is designed to complement existing school curricula by targeting high-risk youth through specialized personality-focused coping strategies rather than universal lecturing. What clinical tool measures substance use risk in this trial? Primary substance-related problems are evaluated using the CRAFFT screening tool, where a score of 2 or higher indicates a positive risk screen. When will effectiveness results for the CUSP trial be published? Data collection is complete, and outcome analyses are currently underway following the finalized, pre-specified statistical analysis plan. ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).